BridgeBio Pharma, Inc. (BBIO)
Nasdaq: BBIO · CIK 0001743881 · United States
Every official BridgeBio Pharma, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open BBIO filings
BridgeBio Pharma, Inc. documents
- BridgeBio Pharma, Inc. 10-K 2026BBIO 10-K 2026: annual report for fiscal 2026
- BridgeBio Pharma, Inc. 10-K 2025BBIO 10-K 2025: annual report for fiscal 2025
- BridgeBio Pharma, Inc. 10-K 2024BBIO 10-K 2024: annual report for fiscal 2024
- BridgeBio Pharma, Inc. 10-K 2023BBIO 10-K 2023: annual report for fiscal 2023
- BridgeBio Pharma, Inc. 10-K 2022BBIO 10-K 2022: annual report for fiscal 2022
- BridgeBio Pharma, Inc. 10-Q 2026BBIO 10-Q 2026: quarterly report for fiscal 2026
- BridgeBio Pharma, Inc. 10-Q 2025BBIO 10-Q 2025: quarterly report for fiscal 2025
- BridgeBio Pharma, Inc. 10-Q 2024BBIO 10-Q 2024: quarterly report for fiscal 2024
- BridgeBio Pharma, Inc. 10-Q 2023BBIO 10-Q 2023: quarterly report for fiscal 2023
- BridgeBio Pharma, Inc. 10-Q 2022BBIO 10-Q 2022: quarterly report for fiscal 2022
- BridgeBio Pharma, Inc. 8-K 2026BBIO 8-K 2026: current report for fiscal 2026
- BridgeBio Pharma, Inc. 8-K 2025BBIO 8-K 2025: current report for fiscal 2025
- BridgeBio Pharma, Inc. 8-K 2024BBIO 8-K 2024: current report for fiscal 2024
- BridgeBio Pharma, Inc. 8-K 2023BBIO 8-K 2023: current report for fiscal 2023
- BridgeBio Pharma, Inc. 8-K 2022BBIO 8-K 2022: current report for fiscal 2022
- BridgeBio Pharma, Inc. DEF 14A 2026BBIO DEF 14A 2026: proxy statement for fiscal 2026
- BridgeBio Pharma, Inc. DEF 14A 2025BBIO DEF 14A 2025: proxy statement for fiscal 2025
- BridgeBio Pharma, Inc. DEF 14A 2024BBIO DEF 14A 2024: proxy statement for fiscal 2024
- BridgeBio Pharma, Inc. DEF 14A 2023BBIO DEF 14A 2023: proxy statement for fiscal 2023
- BridgeBio Pharma, Inc. DEF 14A 2022BBIO DEF 14A 2022: proxy statement for fiscal 2022
- BridgeBio Pharma, Inc. Form 4 2026BBIO Form 4 2026: insider trading filing for fiscal 2026
- BridgeBio Pharma, Inc. Form 4 2025BBIO Form 4 2025: insider trading filing for fiscal 2025
- BridgeBio Pharma, Inc. Form 4 2024BBIO Form 4 2024: insider trading filing for fiscal 2024
- BridgeBio Pharma, Inc. Form 4 2023BBIO Form 4 2023: insider trading filing for fiscal 2023
- BridgeBio Pharma, Inc. Form 4 2022BBIO Form 4 2022: insider trading filing for fiscal 2022
- BridgeBio Pharma, Inc. S-1 2026BBIO S-1 2026: registration statement for fiscal 2026
- BridgeBio Pharma, Inc. S-1 2025BBIO S-1 2025: registration statement for fiscal 2025
- BridgeBio Pharma, Inc. S-1 2024BBIO S-1 2024: registration statement for fiscal 2024
- BridgeBio Pharma, Inc. S-1 2023BBIO S-1 2023: registration statement for fiscal 2023
- BridgeBio Pharma, Inc. S-1 2022BBIO S-1 2022: registration statement for fiscal 2022
- BridgeBio Pharma, Inc. 13F 2026BBIO 13F 2026: institutional holdings for fiscal 2026
- BridgeBio Pharma, Inc. 13F 2025BBIO 13F 2025: institutional holdings for fiscal 2025
- BridgeBio Pharma, Inc. 13F 2024BBIO 13F 2024: institutional holdings for fiscal 2024
- BridgeBio Pharma, Inc. 13F 2023BBIO 13F 2023: institutional holdings for fiscal 2023
- BridgeBio Pharma, Inc. 13F 2022BBIO 13F 2022: institutional holdings for fiscal 2022
More companies